Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Phase I/IIa Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients

NCT03102398 is registered in ClinicalTrials.gov with Tritech Biopharmaceuticals Co., Ltd. as lead sponsor.

NCT NCT03102398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03102398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Phase I/IIa Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients
Lead sponsor
Tritech Biopharmaceuticals Co., Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2017
Completion date
March 31, 2018
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction